{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-009747","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2026-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.322907+00:00","generated_at":"2026-05-16T05:23:06.737579+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Gain Therapeutics posts updated corporate presentation on website","bullets":["Presentation filed as Exhibit 99.1 on Form 8-K dated February 3, 2026.","Slides describe business overview; only cover page and disclaimer are in filed text.","No financial results, pipeline updates, or guidance disclosed in the exhibit.","Investor presentation routine; no material new information provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-009747","json":"https://secwatch.observer/filing/0001104659-26-009747.json","markdown":"https://secwatch.observer/filing/0001104659-26-009747.md","text":"https://secwatch.observer/filing/0001104659-26-009747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926009747/0001104659-26-009747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926009747/tm265021d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:23:06.737579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}